The FDA has approved the Phase III trial design for Ocugen’s NeoCart, the company announced Friday.
Share: email Subscribe
Weekly Top Stories Tue, 20 Dec 2022
We have 30 articles this week. #Synthetic Biology Welcomes #Enlaza Therapeutics to the Game. #Prenetics Acquires #ACT Genomics, Creating a Leader in Comprehensive #Cancer Genetics and #Precision Oncology. Hong Kong mobile telemedicine app #DrGo adds FibriCheck a-fib screening. Federal appeals court temporarily blocks generics of #Vanda's Hetlioz by Teva, Apotex. # NeoCart's Revival Continues as FDA Approves #Ocugen's Phase III Trial Design. # Pangea Biomed Adds $5M for its # Multi-Cancer Response Predictor. #Aktivolabs snaps up $10M in Series A funding and more briefs. # Brain-computer interface company #Synchron raises $75M and more digital health funding
Editor's Choice
1. 
 NeoCart’s Revival Continues as FDA Approves Ocugen’s Phase III Trial Design
2. 
 Pangea Biomed Adds $5M for its Multi-Cancer Response Predictor
3. 
 To Truly Address Behavioral Health Worker Shortages, We Need Telemedicine
4. 
 HearUSA to Carry Sony’s Over-the-Counter Hearing Aids
5. 
 3 Elements Required for Data Ecosystems to Drive Innovation
Top 08 M&A Transactions
6. 
 Synthetic Biology Welcomes Enlaza Therapeutics to the Game
7. 
 Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
8. 
 Modernizing Data Access: 3 Tips for Securing Patient Data in the Cloud
9. 
 Hong Kong mobile telemedicine app DrGo adds FibriCheck a-fib screening
10. 
 Everest Medicines Announces New mRNA Rabies Vaccine Program and Achievement of Preclinical Proof-of-Concept Milestone
11. 
 First patient cells were collected in XNK’s preclinical bladder cancer study.
12. 
 Velocity Clinical Research acquires Meridian Clinical Research creating the largest global research sites business
13. 
 Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development
Top 3 Venture Funding
14. 
 Aktivolabs snaps up $10M in Series A funding and more briefs
15. 
 Brain-computer interface company Synchron raises $75M and more digital health fundings
16. 
 Takeda Bets $4B Upfront on Nimbus’ TYK2 Inhibitor
Top 4 Partnerships Announcements
17. 
 Violet Partners with Ontrak Health to Improve Inclusive Care
18. 
 Titan Pharmaceuticals Provides Shareholder Update
19. 
 AVRA Medical Robotics, Inc. (OTC: AVMR) PROVIDES UPDATE ON MERGER
20. 
 Memora Health and PeriGen partner to coordinate postpartum healthcare
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us